کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3203199 | 1201991 | 2007 | 7 صفحه PDF | دانلود رایگان |

BackgroundExhaled breath contains thousands of volatile organic compounds (VOCs) that could serve as biomarkers of lung disease. Electronic noses can distinguish VOC mixtures by pattern recognition.ObjectiveWe hypothesized that an electronic nose can discriminate exhaled air of patients with asthma from healthy controls, and between patients with different disease severities.MethodsTen young patients with mild asthma (25.1 ± 5.9 years; FEV1, 99.9 ± 7.7% predicted), 10 young controls (26.8 ± 6.4 years; FEV1, 101.9 ± 10.3), 10 older patients with severe asthma (49.5 ± 12.0 years; FEV1, 62.3 ± 23.6), and 10 older controls (57.3 ± 7.1 years; FEV1, 108.3 ± 14.7) joined a cross-sectional study with duplicate sampling of exhaled breath with an interval of 2 to 5 minutes. Subjects inspired VOC-filtered air by tidal breathing for 5 minutes, and a single expiratory vital capacity was collected into a Tedlar bag that was sampled by electronic nose (Cyranose 320) within 10 minutes. Smellprints were analyzed by linear discriminant analysis on principal component reduction. Cross-validation values (CVVs) were calculated.ResultsSmellprints of patients with mild asthma were fully separated from young controls (CVV, 100%; Mahalanobis distance [M-distance], 5.32), and patients with severe asthma could be distinguished from old controls (CVV, 90%; M-distance, 2.77). Patients with mild and severe asthma could be less well discriminated (CVV, 65%; M-distance, 1.23), whereas the 2 control groups were indistinguishable (CVV, 50%; M-distance, 1.56). The duplicate samples replicated these results.ConclusionAn electronic nose can discriminate exhaled breath of patients with asthma from controls but is less accurate in distinguishing asthma severities.Clinical implicationThese findings warrant validation of electronic noses in diagnosing newly presented patients with asthma.
Journal: Journal of Allergy and Clinical Immunology - Volume 120, Issue 4, October 2007, Pages 856–862